| Liu, Lijun |
NCT03021330: Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML |
|
|
| Recruiting | 3 | 1100 | RoW | Daunomycin and Cytarabine (DA Regimen), Daunomycin and Cytarabine, Daunomycin and Cytarabine (Intermediate Dose of DA Regimen) | Institute of Hematology & Blood Diseases Hospital, China | AML | 12/24 | 12/24 | | |
NCT04983043: Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure |
|
|
| Completed | 2 | 228 | RoW | Low dose QiShen YiQi Dripping Pills 3 bags, Low dose group, High dose QiShen YiQi Dripping Pills 3 bags, High dose group, QiShen YiQi Dripping Pills placebo 3 bags, Placebo group | Tasly Pharmaceutical Group Co., Ltd | Chronic Heart Failure With Reduced Ejection Fraction | 11/24 | 11/24 | | |
NCT03031249: Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia |
|
|
| Recruiting | 1/2 | 80 | RoW | Cytarabine, HDAC, all-trans retinoic acid, ATRA, Arsenic Trioxide, ATO | Institute of Hematology & Blood Diseases Hospital | AML | 12/21 | 12/22 | | |
NCT03031262: Efficacy and Safety of Chidamide in CBF Leukemia |
|
|
| Recruiting | 1/2 | 250 | RoW | Cytarabine, HDAC, Chidamide | Institute of Hematology & Blood Diseases Hospital | AML | 12/21 | 12/22 | | |
NCT05152732: Safety and Tolerability of VGB-R04 in Patients With Haemophilia B |
|
|
| Recruiting | 1 | 3 | RoW | VGB-R04 | Institute of Hematology & Blood Diseases Hospital | Hemophilia B | 03/25 | 12/25 | | |
| Wang, Jingye |
NCT06155032: Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion |
|
|
| Recruiting | N/A | 272 | RoW | Endovascular therapy, EVT group, Best medical management, Best medical management group | First Affiliated Hospital of Wannan Medical College, The First Affiliated Hospital of Anhui Medical University | Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive | 12/25 | 03/26 | | |
